Why the study?
The study was conducted to examine the prevalence of the JN.1 variant infection in the development and progression of cardiac-related clinical disorders and understand the molecular and physiological pathways connecting JN.1 to cardiovascular health.
Design
Literature review
Authors
Loading...
JN.1 cardiac associations from Level 5 data should not yet change practice; leaves open need for prospective validation.
The JN.1 variant of SARS-CoV-2 poses a significant public health concern due to its potential to cause cardiovascular complications via ACE2 downregulation and hyperinflammatory responses.
Chhotaray et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: